Sumitomo Pharma CEOs: 7 Presidents Since 1955

Revenue and CEOs7 CEOs
Sumitomo Pharma
CEOs and long-term results
FY2026
Consolidated
Revenue
¥453.3 billion
Net margin
23.6%
Tokujiro MiyatakeMoritakeKenjiro MiyatakeTadaNomuraKimura
Revenue¥32.1 billionRevenue¥142.7 billionRevenue¥245.7 billionRevenue¥403.2 billionRevenue¥453.3 billionNet margin0.3%Net margin3.5%Net margin6.2%Net margin6.1%Net margin23.6%1971/31976/31981/31986/31991/31996/32001/32006/32011/32016/32021/32026/3
Revenue¥245.7 billionRevenue¥453.3 billionNet margin6.2%Net margin23.6%1971/31976/31986/31996/32006/32016/32026/3
Tenure timeline
Presidents7